GoHealth Inc has put together a string of several quarters with positive operating cash flow on a trailing-twelve month basis, showing clear signs of stabilizing. During the third quarter of 2024, they acquired the agency e-TeleQuote on highly favorable terms, expanding their business with little immediate downside risk. Subsequent to the close of the third quarter, GoHealth also refinanced its debt on improved terms, and the interest savings should be meaningful to income and cash flow.
GoHealth, Inc. (NASDAQ:GOCO ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants John Shave - Vice President, Investor Relation Vijay Kotte - Chief Executive Officer Brendan Shanahan - Chief Financial Officer Conference Call Participants Patrick McCann - Noble Capital Markets Ben Hendrix - RBC Capital Markets Robert McGuire - Granite Research James Sidoti - Sidoti Operator Good morning and welcome to GoHealth's Third Quarter 2024 Earnings Conference Call. My name is Hope, and I will be your operator for today's call.
GoHealth (GOCO) came out with a quarterly loss of $3.73 per share versus the Zacks Consensus Estimate of a loss of $3.19. This compares to loss of $2.61 per share a year ago.
Health insurance marketplace GoHealth has inked an agreement to buy Medicare-focused e-TeleQuote. The acquisition is expected to close Sept.
GoHealth, Inc. (NASDAQ:GOCO ) Q2 2024 Earnings Conference Call August 7, 2024 8:00 AM ET Company Participants John Shave - Vice President, Investor Relations Vijay Kotte - Chief Executive Officer Katie O'Halloran - Interim Chief Financial Officer Conference Call Participants Ben Hendrix - RBC Capital Markets Pat McCann - Noble Capital Markets Jim Sidoti - Sidoti & Co. Sandeep Soorya - Delaware Street Capital Operator Good morning. And welcome to GoHealth Second Quarter 2024 Earnings Conference Call.
GoHealth (GOCO) came out with a quarterly loss of $0.75 per share versus the Zacks Consensus Estimate of a loss of $2.47. This compares to loss of $1.77 per share a year ago.
GoHealth (GOCO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against GoHealth, Inc. (NASDAQ:GOCO). The settlement provides for a fund of $29,250,000 to benefit class members.
NEW YORK, NY / ACCESSWIRE / June 6, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against GoHealth, Inc. (NASDAQ: GOCO). The settlement provides for a fund of $29,250,000 to benefit class members.
NEW YORK, NY / ACCESSWIRE / June 4, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against GoHealth, Inc. (NASDAQ: GOCO). The settlement provides for a fund of $29,250,000 to benefit class members.
NEW YORK, NY / ACCESSWIRE / May 30, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against GoHealth, Inc. (NASDAQ: GOCO). The settlement provides for a fund of $29,250,000 to benefit class members.
GoHealth's shares have continued to drop despite positive developments, presenting an opportunity for investors to build a position over time. The company has shown positive operating cash flow for five consecutive quarters, reflecting a shift towards profitability and cost containment. Although GOCO previously needed to rely on debt funding, it is now deleveraging, and its focus on operating cash flow is a positive sign for investors.